---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-057380"
form_type: "8-K"
ticker: null
cik: "0001733413"
company_name: "TFF Pharmaceuticals, Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:05:13.748896+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# TFF Pharmaceuticals board member Michael Patane resigns effective June 30, 2024

## Summary
- Michael Patane resigned from the Board of Directors, effective June 30, 2024.
- No reason for the resignation was disclosed in the filing.
- No successor or replacement board member has been announced.

## SEC filing metadata
- accession: 0001213900-24-057380
- form_type: 8-K
- cik: 0001733413
- company_name: TFF Pharmaceuticals, Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733413/000121390024057380/0001213900-24-057380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733413/000121390024057380/ea0208732-8k_tffpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-057380
- JSON: https://secwatch.observer/filing/0001213900-24-057380.json
- Plain text: https://secwatch.observer/filing/0001213900-24-057380.txt

## Key facts
- Executive change
  Michael Patane resigned as Director at TFF Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Director
  source text: On June 26, 2024, Michael Patane tendered his resignation from our Board of Directors effective as of June 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1733413/000121390024057380/0001213900-24-057380-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.